Lifespan assay of C. elegans in control and DR groups
Original Article
21 Jul, 2025

Effect of Dietary Restriction on the Healthspan of Caenorhabditis elegans

Mental health status of caregivers
Original Article
21 Jul, 2025

Caregivers’ Burden of Patients with Severe Mental Illnesses: A Cross-sectional Study

Cumulative overall temperature effects on all-cause mortality at different lag periods for Kedah states. The DLNM cross basis functions with 3 df for the temperature and 4 df for the lag dimension. The reference was at the minimum mortality temperature (MMT). Blue lines were the cumulative RR, and the dotted lines are 95% confidence interval. (a) Lag 0-3 (a) and (b) 0-7: J-shaped pattern; (c) lag 0-14: U-shaped pattern; (d) lag 0-21 and (e) 0-28: L-shaped pattern
Original Article
21 Jul, 2025

Temperature Related Mortality in A Tropical Climate Country: A Time Series Analysis

Original Article
21 Jul, 2025

Factors Associated with Electroencephalographic Epileptiform Abnormalities in Epilepsy Patients: A Cross-sectional Study

All K+ levels are in mmol/L. *RAAS-i = ACE-i/ARB, ARNI and MRA. [ACE-i: angiotensin-converting enzyme inhibitor; AKI: acute kidney injury; ARB: angiotensin II receptor blocker; ARNI: angiotensin receptor-neprilysin inhibitor; CKD: chronic kidney disease; CPS: calcium polystyrene sulfonate; ECG: electrocardiogram; ED: emergency department; HF: heart failure; K+: potassium; MRA: mineralocorticoid receptor antagonist; NSAID: non-steroidal anti-inflammatory drug; PO: orally; TDS: three times daily; RAAS-i: reni
Original Article
21 Jul, 2025

Executive Summary of the Malaysian Consensus on the Management of Acute and Persistent Hyperkalaemia: A Multidisciplinary Approach

(A) K-Force® Grip dynamometer and Baseline® Grip dynamometer; (B) Grip strength; (C) Grip strength assessment with the Baseline® Grip dynamometer
Original Article
21 Jul, 2025

Investigation of the Validity and Reliability of the K-Force® Grip Dynamometer in the Evaluation of Hand Grip Strength in Individuals with Carpal Tunnel Syndrome

Analysis of miRNA expression profile with metformin treatment in high glucose-induced HUVECs (¬n = 3) (A) The differential expression of miRNAs in high glucose-induced HUVECs treated with metformin, showing both up-regulated (red) and down-regulated (blue) miRNAs; (B) a volcano plot displaying the fold change of miRNA expression in the samples (log2 fold change) with their statistical significance (-log10 (p-value)), color-coded to distinguish the significantly upregulated (red), downregulated (blue), and n
Original Article
21 Jul, 2025

Metformin Alters the MicroRNA Profile of High Glucose-Induced Human Umbilical Vein Endothelial Cells